Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Smoking and peripheral vascular disorders]

F Stammler1, C Diehm

  • 1Rehabilitationskrankenhaus Karlbsbad-Langensteinbach, Akademisches Lehrkrankenhaus, Universität Heidelberg.

Zeitschrift Fur Arztliche Fortbildung
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MMW Fortschritte der Medizin·2019
Same author

MMW Fortschritte der Medizin·2019
Same author

Pregnancy stress, healthy pregnancy and birth outcomes - the need for early preventative approaches in pregnant Australian Indigenous women: a prospective longitudinal cohort study.

Journal of developmental origins of health and disease·2019
Same author

MMW Fortschritte der Medizin·2018
Same author

Influence of maternal adiposity, preterm birth and birth weight centiles on early childhood obesity in an Indigenous Australian pregnancy-through-to-early-childhood cohort study.

Journal of developmental origins of health and disease·2018
Same author

MMW Fortschritte der Medizin·2018

Smoking cessation is crucial for peripheral arterial occlusive disease (PAOD) and thrombangiitis obliterans (TAO) patients. Combined nicotine replacement therapy and behavioral treatment improve smoking cessation success rates.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Research
  • Addiction Medicine

Context:

  • Smoking is a primary risk factor for peripheral arterial occlusive disease (PAOD) and thrombangiitis obliterans (TAO).
  • Nicotine and carboxyhemoglobin in smoke damage endothelial cells, initiating arteriosclerosis.
  • Smoking exacerbates other cardiovascular risk factors like hyperfibrinogenemia and altered cholesterol levels.

Purpose:

  • To highlight the detrimental effects of smoking on PAOD and TAO.
  • To emphasize the critical need for smoking cessation in managing these vascular diseases.
  • To evaluate the efficacy of combined nicotine replacement therapy and behavioral treatment for smoking cessation in affected patients.

Summary:

  • Smoking significantly worsens outcomes for PAOD and TAO patients, increasing amputation and mortality rates.

Related Experiment Videos

  • Despite known risks, many patients continue smoking, necessitating effective cessation strategies.
  • A combined approach using temporary nicotine replacement (patches, gum) alongside behavioral therapy shows improved success in quitting.

    • Impact:

    • Promotes smoking cessation as the most critical therapeutic goal for PAOD and TAO.
    • Offers evidence-based strategies for healthcare providers to assist patients in quitting.
    • Aims to reduce the high amputation and mortality rates associated with continued smoking in vascular disease patients.